期刊
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
卷 624, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.colsurfa.2021.126814
关键词
Type I collagen; Silver nanoparticles; Mesenchymal stem cells; Biocompatibility; Differentiation; Vascular regeneration
资金
- Ministry of Science and Technology, Taiwan [MOST 107-2314-B-039-069]
- China Medical University Hospital, Taiwan [DMR-109-127]
This report presents the preparation of a novel nanocomposite based on type I collagen (Col) containing varying amounts of silver nanoparticles (AgNPs), and evaluates the biological properties and compatibility of Col-Ag with mesenchymal stem cells (MSCs). The study shows that the 30.2 ppm concentration of Col-Ag demonstrates better biological properties and compatibility with MSCs, suggesting its potential for applications in vascular regeneration.
In this report, a novel nanocomposite based on type I collagen (Col) was prepared, which contained varying amounts (15.1, 30.2, and 75.5 ppm) of silver nanoparticles (AgNPs). The surface morphology and chemical composition pure Col and Col-AgNP nanocomposites (Col-Ag) was characterized by UV-Vis spectroscopy (UV-Vis), atomic force microscope (AFM) and Fourier transform IR spectrometer (FTIR). The biocompatibility effect and biological activity of Col-Ag culturing with mesenchymal stem cells (MSCs), as well as guiding for angiogenesis differentiation, were evaluated via in vitro assay. The Col-Ag in 30.2 ppm demonstrated better biological properties and compatibility culturing with MSCs. The biological properties could be associated with cell adhesion, proliferation, migration and differentiation. Afterwards, the induced angiogenesis and differentiation of MSCs by the expression of von Willebrand Factor (vWF) and CD31 were also investigated. Furthermore, both anti-inflammatory and endothelialization ability were also investigated in vivo assay. It was observed that Surfaces Physicochemical Engineering Col-Ag nanocomposites not only inhibited CD86 expression, but also facilitated endothelialization capacity, the expression of CD31 when implanting Col-Ag into rats subcutaneously after 4 weeks. This current research indicates that Col-Ag nanocomposites has potential of being employed as a surface modification approach, and is better in clinical treatments with MSCs for vascular regeneration applications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据